Following a string of losses in federal courts, some drugmakers are now turning to state-level courts in an effort to [...] …
Category: Legislative
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added another major [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. told a U.S. Senate subcommittee Tuesday that the 340B program [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The California Assembly yesterday approved a bill to prohibit manufacturers from placing 340B contract pharmacy restrictions on grantee covered entities, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Oklahoma Gov. Kevin Stitt (R) on Saturday vetoed a 340B contract pharmacy access despite it passing the Republican-controlled state legislature [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Vermont state senators voted by voice Thursday to pass a 340B contract pharmacy access bill with recently added reporting requirements [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s first public remarks on the 340B program—which 340B Report broke [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key U.S. House Committee voted along party lines Wednesday to approve the GOP’s wide-ranging health care reconciliation budget provisions—some [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With a Saturday deadline looming, Oklahoma Gov. Kevin Stitt (R) is facing pressure from dark money groups and drug industry-funded [...] …